NOVACYT Aktie
| 0,62EUR | -0,17EUR | -21,66% |
WKN DE: A12CFH / ISIN: FR0010397232
Personal
| 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Personal am Ende des Jahres | 0 | 0 | 0 | 0 | 0 |
| Umsatz pro Mitarbeiter in Mio. EUR | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
Bilanz (in Mio. EUR) - Aktiva
| 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Summe Umlaufvermögen | 189 | 143 | 72 | 48 | 32 |
| Summe Anlagevermögen | 30 | 15 | 83 | 38 | 14 |
| Summe Aktiva | 219 | 159 | 154 | 85 | 46 |
Bilanz (in Mio. EUR) - Passiva
| 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Summe Fremdkapital | 50 | 29 | 54 | 28 | 19 |
| Summe Eigenkapital | 169 | 130 | 101 | 58 | 27 |
| Summe Passiva | 219 | 159 | 154 | 85 | 46 |
Adresse
| 131 Boulevard Carnot, 78110 Le Vésinet | |
| Telefon | +33 (1) 39-46-51-04 |
| Fax | +33 (1) 30-70-05-32 |
| Internet | http://www.novacyt.com |
Management
|
Ian David Gilham
Non-Executive Director |
|
Jean-Pierre Crinelli
Independent Non-Executive Director |
|
Joanne Nicola Mason
Chief Scientific Officer & Executive Director |
|
John Robert Brown
Chairman |
|
Juliet Thompson
Independent Non-Executive Director |
|
Lyn Dafydd Rees
Chief Executive Officer & Executive Director |
|
Maria Watters
Chief Commercial Officer |
|
Peter Coyne
Chief Operations Officer |
|
Steven Michael Gibson
Chief Financial Officer & Executive Director |
|
Wendy Cox
Director-Human Resources |